Clinical Trials Directory

Trials / Completed

CompletedNCT05855343

Exploratory Study of Switching From Combustible Cigarettes to the BIDI E-cigarette

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Rose Research Center, LLC · Industry
Sex
All
Age
22 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to shed light on the importance of nicotine pharmacokinetics in switching to a reduced-harm product by fully matching the nicotine pharmacokinetics of smokers' usual brands of cigarettes. The primary objective is to ascertain the degree of smoking reduction when smokers attempt to switch to an e-cigarette that matches peak nicotine concentrations of a cigarette.

Conditions

Interventions

TypeNameDescription
OTHERBIDI Stick e-cigaretteThe BIDI will be dispensed, and subjects will be instructed to use the BIDI as often as they like during the 12 week period, and to switch completely to the BIDI within 1 week. If, however, they do smoke any CC, they will also be instructed to use the BIDI immediately before each CC to relieve their craving as much as possible before smoking their usual brand. The BIDI will also be the first product that they are instructed to use each morning. Smokers will be told to try to completely substitute BIDI for CCs by the end of the first week of use.

Timeline

Start date
2023-02-14
Primary completion
2023-09-05
Completion
2023-12-05
First posted
2023-05-11
Last updated
2024-03-19

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05855343. Inclusion in this directory is not an endorsement.